It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings ...

We recently compiled a list of the 11 Most Expensive Stocks Insiders Are Buying Recently. In this article, we are going to ...

Shares of Merck & Co. Inc. MRK rallied 2.08% to $89.50 Friday, on what proved to be an all-around rough trading session for ...

After the Duchess of Sussex announced her American Riviera Orchard rebrand, she once again is facing accusations of ...

Few youngsters might recognize Maurice Hilleman as the man behind their childhood immunizations. But with more than 40 vaccines to his credit, it's no exaggeration to say Hilleman saves millions ...